The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this. Whatever happens, though ...
StockStory.org on MSN10h
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The PackLet’s dig into the relative performance of Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers as we unravel the now-completed ...
Steward Partners Investment Advisory LLC acquired a new position in shares of Vertex, Inc. (NASDAQ:VERX – Free Report) in the ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
4h
Zacks.com on MSNCRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?The fall in CRSP stock can be attributed to a lack of pipeline updates. Despite securing approval for its first marketed product in early 2024, it is yet to record product sales.
9h
GlobalData on MSNArbor to advance gene editing treatments with $73.9m fundingArbor Biotechnologies has closed $73.9m for its gene editing therapeutic pipeline aimed at liver and central nervous system ...
Vertex Minerals Ltd. ( ($AU:VTX) ) has issued an update. Vertex Minerals Limited has announced the acquisition of an Aramine L350D Loader for its ...
Federal Territory of Kuala Lumpur, Malaysia, March 19, 2025 -- SurgeGraph, one of the leading AI writing tools, has announced ...
Google on Tuesday revealed improvements to its search engine for health care, including a feature that allows users with ...
Artificial general intelligence may be years away, but in the meantime, organisations are being urged to adopt agent ...
Internet and connectivity services company Google Cloud has launched its first cloud region for countries in sub-Saharan ...
Vertex Pharmaceuticals is ranked among the best biotech stocks to buy, with 13 billionaires backing the company. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results